Five Billion Mectizan Treatments Donated…and Counting: Merck & Co., Inc.’s* Dr. Allison Goldberg Interviews with Devex and the END Fund Devex In her interview with
The Mectizan Donation Program in 2024 LEGACY—Honoring the visionaries to secure the future. This annual report publication summarizes the accomplishments of the Mectizan Donation
Report from the InterAmerican Conference on Onchocerciasis XXXV In November, MDP participated in the Onchocerciasis Elimination Program for the Americas (OEPA) 35th InterAmerican Conference
These are some journal articles published on topics relating to onchocerciasis and lymphatic filariasis by members of the Mectizan Expert Committee/Albendazole Coordination in 2025.
(Video: Five Billion Mectizan Treatments – The Americas) Os quatro primeiros países a eliminar a oncocercose com Mectizan estão nas Américas: Colômbia, Equador,
(Video: Five Billion Mectizan Treatments – The Americas) Los primeros cuatro países en eliminar la oncocercosis con Mectizan se encuentran en las Américas: Colombia,
Colombia, Ecuador, Guatemala, and Mexico were the first four countries in the world to eliminate river blindness with Mectizan, freeing more than 450,000 people
Merck Commemorates 5 Billion Mectizan® Treatments Donated Over 38 Years November 17, 2025 6:45 am EST Extension of Mectizan Donation for Triple Therapy Advances
The 1987 donation of Mectizan by Merck* for river blindness sparked one of global health’s most successful public-private partnerships. Collaboration among governments, NGOs, WHO,
Despite the ongoing civil war creating extremely difficult challenges to the NTD program, Yemen successfully eliminated LF as a public health problem in 2019.
The integrated transmission assessment survey (iTAS), a modification of the transmission assessment survey for LF, offers an opportunity to co-evaluate transmission levels of both
Weekly epidemiological record 10 October 2024 No. 41, 2025, 100, 461–467 Report from the InterAmerican Conference on Onchocerciasis (IACO) 2024 Contains information about ivermectin
For decades, the World Health Organization (WHO) has played a key role in combating river blindness and lymphatic filariasis by providing leadership, coordinating partners,
Weekly epidemiological record 10 October 2025 No 41, 2025, 100, 451–468 Onchocerciasis, or river blindness, remains a major public health challenge despite decades of
Weekly Epidemiological Record 3 October 2025 No 40, 2025, 100, 439–450 This annual report from the World Health Organization provides the following information: Achievements
National Onchocerciasis Elimination Committees (NOECs) play a vital role in national neglected tropical disease (NTD) programs. The purpose of this handbook is to provide
River blindness and lymphatic filariasis (LF) are devastating parasitic diseases threatening millions of people worldwide. To interrupt transmission and achieve elimination, it is essential
The eighth meeting of the WHO Onchocerciasis Technical Advisory Subgroup (OTS) was held on 9–12 December 2024 in Toledo, Spain. The meeting commenced with
